The spread of SARS-CoV-2 variant Omicron with the doubling time of 2.0–3.3 days can be explained by immune evasion

Frederic Grabowski, Marek Kochańczyk, Tomasz LipniackimedRxiv 2021 · DOI

Abstract

Omicron, the novel highly mutated SARS-CoV-2 Variant of Concern (VOC, Pango lineage B.1.1.529), was first collected in early November 2021 in South Africa. By the end of November 2021, it had spread and approached fixation in South Africa, and had been detected on all continents. We analyzed the exponential growth of Omicron over the four-week periods in two most populated South Africa’s provinces, Gauteng and KwaZulu-Natal, arriving at the doubling time estimates of respectively 3.3 days [95% CI: 3.2–3.4 days] and 2.7 days [95% CI: 2.3–3.3 days]. Similar or even shorter doubling times were observed in other locations: Australia (3.0 days), New York State (2.5 days), UK (2.4 days), and Denmark (2.0 days). Log–linear regression suggests that the spread began in Gauteng around October 11, 2021, however, due to presumable stochasticity in the initial spread, this estimate can be inaccurate. Phylogenetics-based analysis indicates that the Omicron strain started to diverge in between October 6 and October 29, 2021. We estimated that the weekly growth of the ratio of Omicron to Delta is in the range 7.2–10.2, considerably higher than the growth of the ratio of Delta to Alpha (estimated to be in the range 2.5–4.2), and Alpha to pre-existing strains (estimated to be in the range of 1.8–2.7). High relative growth does not necessarily imply higher Omicron infectivity. A two-strain SEIR model suggests that the growth advantage of Omicron may stem from immune evasion, which permits this VOC to infect both the recovered and the fully vaccinated individuals. As we demonstrated within the model, immune evasion is more concerning than increased transmissibility, because it can facilitate larger epidemic outbreaks.

Introduction: Transmissibility or Immune Evasion?

When the Omicron variant (B.1.1.529) emerged in late 2021, it displaced the dominant Delta variant with unprecedented speed. Public health officials faced a critical question: Was Omicron simply more "contagious" (higher intrinsic transmissibility), or was it spreading because existing vaccines and prior infections no longer provided effective barriers?

Distinguishing between these two drivers is vital. If a virus is more transmissible, it spreads faster among the same group of people. If it evades immunity, it effectively "re-opens" the entire population to infection, significantly increasing the potential scale of an outbreak. This paper seeks to quantify Omicron's growth and use mathematical modeling to determine which mechanism best explains the data.

Methodology

The researchers employed a multi-pronged analytical approach:

  • Epidemiological Analysis: Log-linear regression on case data from South Africa (Gauteng and KwaZulu-Natal), the UK, Denmark, New York State, and Australia to calculate doubling times and growth rates.
  • Genomic Tracking: Cross-referencing case counts with genomic sequences from the GISAID database to calculate the "weekly growth of the ratio" between variants.
  • Phylogenetics: Analysis of mutation accumulation rates and phylogenetic trees from Nextstrain to estimate the lineage divergence window (October 6–29, 2021).
  • Mathematical Modeling: A two-strain SEIR (Susceptible-Exposed-Infectious-Recovered) model with a vaccination compartment. Two scenarios were compared: Model A (Omicron is 4x more transmissible) and Model B (Omicron has the same transmissibility but can infect a 4x larger pool due to immune evasion).

Key Results: Global Doubling Times

Omicron showed remarkably consistent doubling times across the globe. In South Africa, the growth was particularly explosive in the most populated provinces, with the spread likely beginning in Gauteng around October 11, 2021.

Estimated Omicron cases in Gauteng and KwaZulu-Natal showing doubling times of 3.3 and 2.7 days.

Key findings include:

  • Doubling Times: 2.0 days in Denmark, 2.4 days in the UK, 2.5 days in New York, and 3.3 days in Gauteng.
  • Growth Rates: The weekly growth rate of the Omicron:Delta ratio was estimated at 7.2 to 10.2, significantly higher than the previous Delta-to-Alpha ratio (2.5–4.2).

Key Insights: The Danger of Immune Evasion

The core insight of the study is that in the early stages of an outbreak, a highly transmissible virus and an immune-evading virus look identical on a growth chart. Both produce the same steep exponential curve. However, the long-term consequences differ significantly.

Comparison of estimated cases for pre-existing, Delta, and Omicron variants in South African provinces.

The authors argue that immune evasion is the more concerning trait. While both models explain the initial 2-3 day doubling time, the "Immune Evasion" model (Model B) predicts a much higher peak—infecting over 3% of the population daily compared to less than 1% in the "High Transmissibility" model. This is reflected in the massive scale of the Omicron wave shown in Figure A, which rapidly displaced Delta and dwarfed previous variant peaks.

Limitations and Future Work

While the study provides robust estimates, it faces certain limitations. Early-stage epidemiological data is inherently "noisy" due to the random nature of initial transmission and potential reporting biases. Furthermore, this analysis focuses strictly on the spread of the virus and does not account for differences in clinical severity, which is a crucial factor for hospital capacity planning. Future work could integrate more granular data on booster effectiveness and waning immunity to provide a more comprehensive picture of the variant's impact.

Summary updated

Abstract

Abstract Omicron, the novel highly mutated SARS-CoV-2 Variant of Concern (VOC, Pango lineage B.1.1.529), was first collected in early November 2021 in South Africa. By the end of November 2021, it had spread and approached fixation in South Africa, and had been detected on all continents. We analyzed the exponential growth of Omicron over the four-week periods in two most populated South Africa’s provinces, Gauteng and KwaZulu-Natal, arriving at the doubling time estimates of respectively 3.3 days [95% CI: 3.2–3.4 days] and 2.7 days [95% CI: 2.3–3.3 days]. Similar or even shorter doubling times were observed in other locations: Australia (3.0 days), New York State (2.5 days), UK (2.4 days), and Denmark (2.0 days). Log– linear regression suggests that the spread began in Gauteng around October 11, 2021, however, due to presumable stochasticity in the initial spread, this estimate can be inaccurate. Phylogenetics-based analysis indicates that the Omicron strain started to diverge in between October 6 and October 29, 2021. We estimated that the weekly growth of the ratio of Omicron to Delta is in the range 7.2–10.2, considerably higher than the growth of the ratio of Delta to Alpha (estimated to be in in the range 2.5–4.2), and Alpha to pre-existing strains (estimated to be in the range of 1.8–2.7). High relative growth does not necessarily imply higher Omicron infectivity. A two-strain SEIR model suggests that the growth advantage of Omicron may stem from immune evasion, which permits this VOC to infect both the recovered and the fully vaccinated individuals. As we demonstrated within the model, immune evasion is more concerning than increased transmissibility, because it can facilitate larger epidemic outbreaks.
BibTeX
@misc{grabowski2021spread,
  author = {Frederic Grabowski and Marek Kochańczyk and Tomasz Lipniacki},
  title = {{The spread of SARS-CoV-2 variant Omicron with the doubling time of 2.0–3.3 days can be explained by immune evasion}},
  year = {2021},
  doi = {10.1101/2021.12.08.21267494},
  howpublished = {medRxiv},
}
Figure